163 related articles for article (PubMed ID: 12570035)
1. Toward optimal health: the experts discuss cognitive function and memory changes.
Park DC; Birge SJ
J Womens Health (Larchmt); 2002 Oct; 11(8):683-9. PubMed ID: 12570035
[No Abstract] [Full Text] [Related]
2. [Neuropause?].
Polo-Kantola P; Riekkinen M
Duodecim; 2003; 119(22):2207-14. PubMed ID: 14702810
[No Abstract] [Full Text] [Related]
3. The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline.
Resnick SM; Coker LH; Maki PM; Rapp SR; Espeland MA; Shumaker SA
Clin Trials; 2004; 1(5):440-50. PubMed ID: 16279282
[TBL] [Abstract][Full Text] [Related]
4. Toward optimal health: the experts discuss memory loss in aging women.
Espino DV; Andel R
J Womens Health (Larchmt); 2004 Oct; 13(8):856-62. PubMed ID: 15671701
[No Abstract] [Full Text] [Related]
5. Perimenopause: an update.
Woods NF; Mitchell ES
Nurs Clin North Am; 2004 Mar; 39(1):117-29. PubMed ID: 15062731
[TBL] [Abstract][Full Text] [Related]
6. [How will I treat my patient using estrogen?].
Tiitinen A
Duodecim; 2003; 119(22):2227-32. PubMed ID: 14702812
[No Abstract] [Full Text] [Related]
7. [Estrogen therapies--where are we now?].
Ylikorkala O
Duodecim; 2003; 119(22):2175-7. PubMed ID: 14702805
[No Abstract] [Full Text] [Related]
8. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis.
Hogervorst E; Williams J; Budge M; Riedel W; Jolles J
Neuroscience; 2000; 101(3):485-512. PubMed ID: 11113299
[TBL] [Abstract][Full Text] [Related]
9. Toward optimal health: the experts provide a current perspective on perimenopause. Interview by Jodi Godfrey Meisler.
Santoro NF; Woods NF
J Womens Health (Larchmt); 2003 Sep; 12(7):609-15. PubMed ID: 14583102
[No Abstract] [Full Text] [Related]
10. ["Menopause medicine" a growing discipline. Many questions on hormones and women's health are still unanswered].
von Schoultz B
Lakartidningen; 2001 Jan; 98(5):412-6. PubMed ID: 11229081
[No Abstract] [Full Text] [Related]
11. Surgical menopause and cognitive decline.
Pines A
Climacteric; 2014 Oct; 17(5):580-2. PubMed ID: 24502814
[TBL] [Abstract][Full Text] [Related]
12. A women's health issue: Alzheimer's disease and strategies for maintaining cognitive health.
Brinton RD
Int J Fertil Womens Med; 1999; 44(4):174-85. PubMed ID: 10499738
[TBL] [Abstract][Full Text] [Related]
13. Effects of hormone replacement therapy on cognitive and brain aging.
Resnick SM; Maki PM
Ann N Y Acad Sci; 2001 Dec; 949():203-14. PubMed ID: 11795355
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease, menopause and the impact of the estrogenic environment.
Pines A
Climacteric; 2016 Oct; 19(5):430-2. PubMed ID: 27327261
[TBL] [Abstract][Full Text] [Related]
15. [Estrogen during and after climacteric--problems and possibilities for primary health care].
Blivik J
Lakartidningen; 2001 Mar; 98(10):1145-6. PubMed ID: 11301984
[No Abstract] [Full Text] [Related]
16. [Brain dysfunction in climacteric and prevention].
Altieri M; Bogousslavsky J
Praxis (Bern 1994); 1997 Sep; 86(36):1378-82. PubMed ID: 9381032
[TBL] [Abstract][Full Text] [Related]
17. [Is estrogen replacement therapy increasing or decreasing the risk of cancer?].
Auranen A; Grénman S; Anttila L; Salmi T
Duodecim; 2003; 119(22):2199-206. PubMed ID: 14702809
[No Abstract] [Full Text] [Related]
18. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review.
Sherwin BB; Henry JF
Front Neuroendocrinol; 2008 Jan; 29(1):88-113. PubMed ID: 17980408
[TBL] [Abstract][Full Text] [Related]
19. [Quality of life from estrogen].
Rutanen EM
Duodecim; 2003; 119(22):2217-23. PubMed ID: 14702811
[No Abstract] [Full Text] [Related]
20. [Estrogen and cardiovascular diseases].
Mikkola T; Tikkanen MJ
Duodecim; 2003; 119(22):2191-7. PubMed ID: 14702808
[No Abstract] [Full Text] [Related]
[Next] [New Search]
